La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « In vitro »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
In situ hybridization < In vitro < In vitro superfusion  Facettes :

List of bibliographic references indexed by In vitro

Number of relevant bibliographic references: 53.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
001417 (2012) Faraj Terro [France] ; Amandine Magnaudeix [France] ; Marion Crochetet [France] ; Ludovic Martin [France] ; Sylvie Bourthoumieu [France] ; Cornelia-M. Wilson [France] ; Catherine Yardin [France] ; Philippe Leveque [France]GSM-900 MHz at low dose temperature-dependently downregulates α-synuclein in cultured cerebral cells independently of chaperone-mediated-autophagy
001846 (2011) Ngoc-Duc Doan [Canada] ; Steve Bourgault [Canada] ; Agnieszka Dejda [Canada] ; Myriam Letourneau [Canada] ; Michel Detheux [Belgique] ; David Vaudry [Canada, France] ; Hubert Vaudry [Canada, France] ; David Chatenet [Canada] ; Alain Fournier [Canada]Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects
001D11 (2010) Fanny Schmiijt [France] ; Gael Le Douaron [France] ; Pierre Champy [France] ; Majid Amar [France] ; Blandine Seon-Meniel [France] ; Rita Raisman-Vozari [France] ; Bruno Figadere [France]Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons
001D22 (2010) B. Pirotte [Belgique] ; P. Francotte [Belgique] ; E. Goffin [Belgique] ; P. Fraikin [Belgique] ; L. Danober [France] ; B. Lesur [France] ; I. Botez [France] ; D.-H. Caignard [France] ; P. Lestage [France] ; P. De Tullio [Belgique]Ring-Fused Thiadiazines as Core Structures for the Development of Potent AMPA Receptor Potentiators
002172 (2009) S. Bourgault [Canada, France] ; D. Vaudry [France] ; A. Dejda [Canada, France] ; N. D. Doan [Canada, France] ; H. Vaudry [France] ; A. Fournier [Canada, France]Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure-Activity Relationships of a Neuroprotective Peptide
002493 (2008) A. Carmona [France, Espagne] ; G. Deves [France] ; R. Ortega [France]Quantitative micro-analysis of metal ions in subcellular compartments of cultured dopaminergic cells by combination of three ion beam techniques
002512 (2008) Carine Chassain [France] ; Guy Bielicki [France] ; Elodie Durand [France] ; Stéphane Lolignier [France] ; Fatma Essafi [Tunisie] ; Amidou Traore [France] ; Franck Durif [France]Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse
002B22 (2006) Anne Clavreul [France] ; Laurence Sindji [France] ; Anne Aubert-Pouëssel [France] ; Jean-Pierre Benoit [France] ; Philippe Menei [France] ; Claudia N. Montero-Menei [France]Effect of GDNF-releasing biodegradable micro spheres on the function and the survival of intrastriatal fetal ventral mesencephalic cell grafts
002D49 (2005) Carmen Henze [France] ; Andreas Hartmann [France] ; Thomas Lescot [France] ; Etienne C. Hirsch [France] ; Patrick P. Michel [France]Proliferation of microglial cells induced by 1-methyl-4-phenylpyridinium in mesencephalic cultures results from an astrocyte-dependent mechanism : role of granulocyte macrophage colony-stimulating factor
002D67 (2005) Carmen Henze [France] ; Thomas Lescot [France] ; Sabine Traver [France] ; Bénédicte Salthun-Lassalle [France] ; Etienne C. Hirsch [France] ; Patrick P. Michel [France] ; Andreas Hartmann [France]Granulocyte colony-stimulating factor is not protective against selective dopaminergic cell death in vitro
002F45 (2004) A. Elbaz [France] ; P. Damier [France]Épidémiologie de la maladie de Parkinson
002F80 (2004) Hélène Legros [France] ; Marie-George Dingeval [France] ; Francois Janin [France] ; Jean Costentin [France] ; Jean-Jacques Bonnet [France]Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: Relationships with 3,4-dihydroxyphenylacetaldehyde formation
003011 (2004) Anne Aubert-Pouëssel [France] ; Marie-Claire Venier-Julienne [France] ; Anne Clavreul [France] ; Michelle Sergent [France] ; Christophe Jollivet [France] ; Claudia N. Montero-Menei [France] ; Emmanuel Garcion [France] ; David C. Bibby [France] ; Philippe Menei [France] ; Jean-Pierre Benoit [France]In vitro study of GDNF release from biodegradable PLGA microspheres
003242 (2003) Jeffrey N. Joyce [États-Unis] ; Steve Presgraves [États-Unis] ; Lynn Renish [États-Unis] ; Sabinne Borwege [États-Unis] ; Tracy Osredkar [États-Unis] ; Diane Hagner [États-Unis] ; Maria Replogle [États-Unis] ; Mateo Pazsoldan [États-Unis] ; Mark J. Millan [France]Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole
003473 (2002) Jean Dessolin [France] ; Marie Schuler [France] ; Alice Quinart [France] ; Francesca De Giorgi [France] ; Leon Ghosez [France] ; Francois Ichas [France]Selective targeting of synthetic antioxidants to mitochondria: towards a mitochondrial medicine for neurodegenerative diseases?
003477 (2002) Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Lucette Garreau [France] ; Denis Guilloteau [France] ; Bernard Fauconneau [France] ; Sylvie Chalon [France]Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat
003492 (2002) Wakako Maruyama [Japon] ; Yukihiro Akao [Japon] ; Maria Chrisina Carrillo [Argentine] ; Ken-Ichi Kitani [Japon] ; Moussa B. H. Youdium [Israël] ; Makoto Naoi [Japon]Neuroprotection by propargylamines in Parkinson's disease: Suppression of apoptosis and induction of prosurvival genes
003493 (2002) Martine Barkats [France] ; Stéphanie Millecamps [France] ; Alicia Bilang-Bleuel [France] ; Jacques Mallet [France]Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine
003501 (2002) Yoko Hirata [Japon]Manganese-induced apoptosis in PC12 cells
003518 (2002) Sophie Callier [France, Canada] ; Maryvonne Le Saux [France] ; Anne-Marie Lhiaubet [France] ; Thérèse Di Paolo [Canada] ; William Rostene [France] ; Didier Pelaprat [France]Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture
003531 (2002) Yoshimi Misu [Japon] ; Nobuya Furukawa [Japon] ; Nobutaka Arai [Japon] ; Takeaki Miyamae [Japon] ; Yoshio Goshima [Japon] ; Kiyohide Fujita [Japon]DOPA causes glutamate release and delayed neuron death by brain ischemia in rats

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "In vitro" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "In vitro" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    In vitro
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024